The Motley Fool

Key Data Points

Primary metrics and data points about Alnylam Pharmaceuticals.
Current Price: $130.17
Prev Close: $128.50
Open: $128.98
Bid: $131.06
Ask: $131.32
Day's Range: $128.40 - $133.96
52wk Range: $51.93 - $133.96
Volume: 647,727
Avg Vol 777,671
Market Cap: $11B
P/E (ttm): -72.60
EPS (ttm): ($1.77)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Alnylam Pharmaceuticals.

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

ALNY vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Alnylam Pharmaceuticals.
CAPS Rating 3 out of 5
366 Outperform
38 Underperform
CAPS All Stars
114 Outperform
13 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John M. Maraganore, CEO

87% Approve

Based on 7 Ratings

More Details for AlnylamJobs

Powered by

More Details about Alnylam Pharmaceuticals

Primary metrics and data points about Alnylam Pharmaceuticals.